What Role Do Near-Infrared Lasers, Such As 800–1000 Nm Diode Lasers And Nd:yag Lasers, Play In Thermal Tissue Ablation And Interstitial Laser Therapy?

Near-infrared lasers convert optical energy into controlled deep-tissue heat. Diode lasers operating around 800–1000 nm and Nd:YAG lasers at 1064 nm penetrate tissue more deeply than many visible wavelengths, allowing energy to be delivered through interstitial fibers directly within a lesion or target tissue. In interstitial laser-induced thermal therapy (LITT), this produces localized hyperthermia and coagulative necrosis, while limiting superficial injury and preserving surrounding structures when treatment parameters are properly controlled.

Near-infrared lasers are valuable in thermal ablation because their tissue penetration and moderate scattering enable heating throughout a target volume rather than only at its surface. The clinical result depends not only on wavelength, but also on fiber placement, power, exposure time, cooling, and temperature monitoring.

Why Near-Infrared Wavelengths Suit Thermal Ablation

They Penetrate Beyond the Surface

The 800–1064 nm range lies broadly within the tissue “optical window,” where absorption by major tissue chromophores is relatively lower than at many shorter wavelengths. This allows light to travel farther into tissue before being converted into heat.

Actual penetration is tissue-dependent. Scattering, water content, blood, melanin, tissue composition, and the presence of carbonized or coagulated tissue all influence how far the energy spreads.

They Produce Distributed Heating

Near-infrared energy is absorbed and scattered within the tissue surrounding the delivery fiber. This creates a region of elevated temperature rather than an effect limited to the fiber tip or tissue surface.

That distribution is important in LITT, where the objective is generally to treat a defined three-dimensional volume. The treatment zone may extend several millimeters from the fiber, depending on the tissue and energy settings.

They Support Coagulation Rather Than Immediate Surface Vaporization

At controlled power and exposure levels, these lasers raise tissue temperature into a range that causes protein denaturation, cellular injury, and vascular coagulation. The tissue is thermally damaged in place rather than instantly removed by surface vaporization.

Temperatures above the coagulation range can cause carbonization and vaporization. These effects may be useful in selected procedures, but they also increase scattering, impede predictable energy delivery, and raise the risk of collateral injury.

The Role of Diode and Nd:YAG Lasers

Diode Lasers Around 800–1000 nm

Diode systems commonly operate near 810 or 940 nm, although specific platforms cover a broader portion of the 800–1000 nm range. Their practical advantages include compact system design, flexible fiber delivery, and the ability to operate in continuous-wave or pulsed modes.

These wavelengths can support interstitial coagulation, vascular sealing, tissue shrinkage, and thermal ablation. Their exact interaction with tissue differs by wavelength because water, blood, and other absorbers do not absorb every near-infrared wavelength equally.

Nd:YAG Lasers at 1064 nm

The 1064 nm Nd:YAG wavelength is well established for deep coagulation and interstitial thermal treatment. Its relatively deep tissue reach makes it useful when the treatment target is below the surface or when a larger volume must be heated from an implanted fiber.

Nd:YAG systems can deliver energy through bare fibers or specialized probes, including cooled applicators. Cooling can reduce excessive heating at the probe-tissue interface while allowing thermal energy to extend into the surrounding target.

The Wavelength Is Only One Variable

A wavelength does not determine the lesion geometry by itself. Fiber position, tissue perfusion, optical properties, power, treatment duration, and the interval between exposures all affect the final ablation zone.

For this reason, clinical protocols typically combine laser settings with imaging, temperature feedback, or other methods of confirming treatment extent.

How Interstitial Laser Therapy Works

Fiber Placement Defines the Treatment Geometry

In interstitial therapy, a thin optical fiber is inserted into or adjacent to the target tissue. The fiber emits laser energy within the tissue, avoiding the need to deliver all energy through the external surface.

This approach can treat deep lesions while reducing unnecessary exposure of overlying tissue. Multiple fibers may be used when the target is large or irregular, although treatment planning becomes more complex.

Heat Causes Progressive Tissue Injury

The biological response depends on both temperature and time. Moderate heating can produce reversible stress or hyperthermia, whereas sustained higher temperatures cause irreversible protein denaturation, cellular death, and coagulative necrosis.

The transition is not a single universal threshold. Blood flow can remove heat, tissue boundaries can conduct it away, and prior coagulation can change the optical and thermal behavior of the region.

Vascular Coagulation Can Support Lesion Regression

Thermal injury can seal or damage small blood vessels within the treatment zone. This reduces perfusion and can contribute to tissue shrinkage, loss of viability, and gradual resorption or regression of the treated lesion.

The same vascular effects can also reduce bleeding in selected soft-tissue procedures. They do not eliminate the need to account for larger vessels, adjacent critical structures, or the possibility of incomplete treatment.

Cooled Probes Modify the Heat Pattern

A cooled probe or cooling sheath can protect the immediate fiber interface from excessive temperature. This helps maintain more predictable energy delivery and may permit treatment of a broader surrounding volume.

Cooling does not make the procedure risk-free. Heat can still spread beyond the intended target, particularly in tissues with limited heat dissipation or near heat-sensitive structures.

Controlling Energy Delivery

Continuous-Wave Operation

Continuous-wave delivery produces sustained heating and is suited to applications requiring direct contact coagulation or progressive thermal accumulation. Lower power settings can be used when the goal is controlled coagulation rather than rapid tissue destruction.

Because heat continues to accumulate during uninterrupted delivery, continuous-wave treatment requires careful attention to exposure time, tissue response, and the distance to adjacent structures.

Pulsed or Chopped Delivery

Pulsed and chopped modes separate energy delivery into short exposures and off-intervals. The pauses allow some heat dissipation and can help restrict thermal spread to the intended tissue layer.

This mode is useful when the operator needs finer control over superficial or soft-tissue effects. The appropriate pulse duration and interval remain procedure- and device-dependent; settings should follow validated clinical protocols rather than being generalized across systems.

Monitoring Makes the Treatment Predictable

Temperature monitoring, imaging, and feedback-controlled systems can help define whether the target has reached a therapeutic thermal dose. MRI-guided LITT is one example in which imaging can assist with treatment planning and monitoring.

Without adequate feedback, the operator must infer treatment extent from delivered energy and tissue response. That approach is less reliable because tissue properties and perfusion vary between patients and anatomical sites.

Understanding the Trade-offs

Deep Penetration Can Increase Collateral Injury

The same penetration that makes NIR lasers useful for deep lesions can expose nearby nerves, vessels, ducts, skin, or other sensitive structures to unwanted heat. Treatment margins must therefore be planned around anatomy, not only around the visible lesion.

Thermal spread is especially important when the target lies close to structures with little tolerance for injury.

Tissue Properties Change During Treatment

As tissue heats, it may coagulate, desiccate, carbonize, or change its optical scattering. These changes can alter how efficiently later laser energy reaches the untreated region.

This is one reason that a fixed power-time calculation may not reliably predict the final ablation volume in every tissue.

Perfusion Can Both Protect and Complicate

Blood flow removes heat and can limit lesion growth, which may protect healthy tissue. It can also prevent the target from reaching a sufficient thermal dose, creating an incomplete or uneven ablation.

Large vessels and highly perfused tissues therefore require particular attention during treatment planning.

Ablation Is Not the Same as Photobiomodulation

Near-infrared light is also discussed in the context of photobiomodulation, but that is a different therapeutic objective. Photobiomodulation generally uses lower-energy exposure intended to influence cellular signaling, whereas LITT deliberately delivers enough thermal energy to injure or destroy tissue.

Claims about specific cellular effects or large changes in growth-factor release should not be automatically applied to thermal ablation procedures. The mechanisms, doses, endpoints, and safety considerations are different.

Making the Right Choice for Your Goal

The appropriate system and protocol should be selected according to the target anatomy, desired lesion volume, tissue optical properties, and available monitoring.

If your primary focus is deep focal ablation: Use an interstitial near-infrared system with carefully planned fiber placement and thermal monitoring, recognizing that 1064 nm Nd:YAG and near-infrared diode lasers can heat tissue beyond the immediate fiber surface.
If your primary focus is vascular coagulation or tissue shrinkage: Select delivery mode, power, and exposure time to achieve controlled coagulation while limiting thermal spread to adjacent structures.
If your primary focus is superficial soft-tissue control: Consider pulsed or chopped delivery where supported by a validated protocol, because off-intervals can reduce cumulative heat buildup.
If your primary focus is predictable treatment margins: Prioritize a system with reliable imaging or temperature feedback rather than choosing solely by wavelength or nominal power.

Used with appropriate planning and monitoring, near-infrared lasers provide a controllable method for converting optical energy into localized therapeutic thermal injury.

Summary Table:

Mechanism	Description	Clinical Significance
Deep penetration	NIR light (800–1064 nm) travels deeper into tissue due to low absorption by chromophores	Allows treatment of subsurface targets without surface damage
Distributed heating	Energy absorbed and scattered creates a volume of elevated temperature	Enables three-dimensional ablation around the fiber
Coagulation	Controlled heating induces protein denaturation and vascular coagulation	Provides hemostasis and tissue destruction without vaporization
Fiber placement	Interstitial fibers deliver energy directly into the target	Allows precise geometry and minimizes superficial injury
Thermal monitoring	Temperature sensors or imaging (e.g., MRI) guide energy delivery	Improves predictability and reduces collateral damage
Pulsed delivery	Chopped exposure allows heat dissipation	Reduces thermal buildup, safer for delicate structures

Enhance your clinic's therapeutic capabilities with BELIS's advanced laser systems, including 800–1000 nm diode and Nd:YAG platforms. Our professional-grade equipment offers precise control for interstitial laser therapy, ensuring optimal outcomes for your patients. Contact us today to learn how our technology can elevate your practice — Consult Our Experts.